2005 (54 POSTS)

Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.

View Abstract

van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D. 2005. Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 10(3):323-33; doi: 10.1111/j.1440-1843.2005.00720.x. PMID: 15955145.

View Abstract

Fukuhara S, Nishimura M, Nordyke RJ, Zaher CA, Peabody JW. 2005. Patterns of care for COPD by Japanese physicians. Respirology 10(3):341-8; doi: 10.1111/j.1440-1843.2005.00717.x. PMID: 15955147.

View Abstract

Brown K, Dingley KH, Turteltaub KW. 2005. Accelerator mass spectrometry for biomedical research. Methods Enzymol 402:423–443; doi: 10.1016/S0076-6879(05)02014-8. PMID: 16401518.

View Abstract

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85(2):429–446; doi: 10.1093/toxsci/kfi135.

View Abstract

Urban JD, Mailman RB. Functional selectivity as a mechanism of action for newer atypical antipsychotic drugs. Presented at Merck, West Point, PA, 2005.

Choksi NY. Current in vitro models of ocular injury and recovery: Vascular assays. Presented at the ICCVAM/NICEATM/ECVAM Ocular Toxicity Scientific Symposium on Mechanisms of Chemically-Induced Ocular Injury and Recovery, May 2005.

Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411; doi: 10.3109/15417060490970430.

View Abstract

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

View Abstract

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090. PMID: 15659567.

View Abstract

Teeguarden JG, Waechter JM, Clewell HJ, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Kester JE, Gentry P, Covington TR, Clewell HJ. Issues in the use of PBPK modeling in the development of cancer slope factors for perchloroethylene. Poster presented at the Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Covington TR, Clewell HJ, Fisher JW, Keys DA, Hack C, Zhao JQ. A harmonized PBPK model for trichloroethylene risk assessment. Poster presented at the Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Kim DJ, Murray I, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. 2005. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 280(10):9519-9527; doi: 10.1074/jbc.M413808200. PMID: 15632134.

View Abstract

Gentry PR, Covington TR, Lawrence G, McDonald T, Snow ET, Germolec D, Moser G, Yager JW, Clewell HJ III. 2005. Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. J Toxicol Environ Health A 68(5):329–351; 10.1080/15287390590900813.

View Abstract

Bauer D, Staskal DF, Diliberto JJ, Birnbaum LS. Disposition of BDE 99 and BDE 153 in female mice. Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Truax JF, Choksi NY, Inhof CJ, Allen DG, Tice RR, Stokes WS. Validation status of the Isolated Rabbit Eye (IRE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005

View Abstract

Allen DG, Choksi NY, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Isolated Chicken Eye (ICE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

View Abstract

Inhof CJ, Choksi NY, Allen DG, Truax JF, Tice RR, Stokes WS. Validation status of the Bovine Corneal Opacity and Permeability (BCOP) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

View Abstract

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Hen’s Egg Test-Chorioallantoic Membrane (HET-CAM) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

View Abstract